FeesSafety
Pluang+

Olema Oncology to present at three major healthcare investor conferences in late 2026

Market News
16 Nov 2026, 23:30 WIB
GlobeNewsWire
View Source
Neutral
Olema Oncology to present at three major healthcare investor conferences in late 2026

Olema Oncology, a clinical-stage biopharmaceutical company focused on breast cancer therapies, announced its participation in three upcoming investor conferences: Evercore Healthcare Conference on November 30, Citi's Global Healthcare Conference on December 1, and Piper Sandler Healthcare Conference on December 2, 2026. These events will feature fireside chats and will be webcast live, providing updates on Olema's progress, including its lead drug candidate palazestrant in Phase 3 trials. This participation highlights Olema's efforts to engage investors as it advances its pipeline of targeted cancer treatments.

Olema Oncology's upcoming investor conference participation is contextually set against the health sector's performance on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 17, 2026 04:12 WIB: out of 150 priced health-sector US stocks, 29 rose and 121 fell. Notable movers include NUWE at USD 4.51 with a -7.96% change, HRTX at USD 0.29 with a -7.54% change and balanced buy/sell activity, and ARWR at USD 44.21 with a -7.47% change.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
2 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
2 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
3 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
4 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App